Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond
Wolfgang Löscher, Pavel Klein
CNS Drugs (2021) Vol. 35, Iss. 9, pp. 935-963
Open Access | Times Cited: 210

Showing 1-25 of 210 citing articles:

Therapeutic Strategies to Ameliorate Neuronal Damage in Epilepsy by Regulating Oxidative Stress, Mitochondrial Dysfunction, and Neuroinflammation
Sahithi Madireddy, Samskruthi Madireddy
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 784-784
Open Access | Times Cited: 42
New epilepsy therapies in development
Pavel Klein, Rafal M. Kaminski, Matthias J. Koepp, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 9, pp. 682-708
Closed Access | Times Cited: 24
Single-Target Versus Multi-Target Drugs Versus Combinations of Drugs With Multiple Targets: Preclinical and Clinical Evidence for the Treatment or Prevention of Epilepsy
Wolfgang Löscher
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 84
Crosstalk between neuroinflammation and oxidative stress in epilepsy
Timothy Fabisiak, Manisha Patel
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 60
Beneficial Effects of Capsaicin in Disorders of the Central Nervous System
Michał Pasierski, Bartłomiej Szulczyk
Molecules (2022) Vol. 27, Iss. 8, pp. 2484-2484
Open Access | Times Cited: 52
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
Bwalya A. Witika, Madan S. Poka, Patrick H. Demana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 836-836
Open Access | Times Cited: 44
Dogs as a Natural Animal Model of Epilepsy
Wolfgang Löscher
Frontiers in Veterinary Science (2022) Vol. 9
Open Access | Times Cited: 40
Recent advances in pharmacotherapy for epilepsy
Amanda W. Pong, Kevin J. Xu, Pavel Klein
Current Opinion in Neurology (2023) Vol. 36, Iss. 2, pp. 77-85
Closed Access | Times Cited: 35
Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments
Wolfgang Löscher, H. Steve White
Cells (2023) Vol. 12, Iss. 9, pp. 1233-1233
Open Access | Times Cited: 34
Pharmacological aspects of antiseizure medications: From basic mechanisms to clinical considerations of drug interactions and use of therapeutic drug monitoring
Cecilie Johannessen Landmark, Sara Eyal, Margrete Larsen Burns, et al.
Epileptic Disorders (2023) Vol. 25, Iss. 4, pp. 454-471
Open Access | Times Cited: 30
Understanding Lamotrigine’s Role in the CNS and Possible Future Evolution
Bárbara Costa, Nuno Vale
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6050-6050
Open Access | Times Cited: 28
Fenfluramine: a plethora of mechanisms?
Jo Sourbron, Lieven Lagae
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 27
Mitochondrial dysfunction in chronic neuroinflammatory diseases (Review)
Pei Qin, Ye Sun, Liya Li
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 5
Open Access | Times Cited: 14
Which terms should be used to describe medications used in the treatment of seizure disorders? An ILAE position paper
Emilio Perucca, Jacqueline A. French, Ghaieb Aljandeel, et al.
Epilepsia (2024) Vol. 65, Iss. 3, pp. 533-541
Open Access | Times Cited: 11
The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System
Ana Beatriz DePaula-Silva
Viruses (2024) Vol. 16, Iss. 1, pp. 119-119
Open Access | Times Cited: 10
Acetylcholine receptor based chemogenetics engineered for neuronal inhibition and seizure control assessed in mice
Quynh-Anh Nguyen, Peter Klein, Cheng Xie, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries
Jakob Christensen, Helga Zoëga, Maarit K. Leinonen, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100849-100849
Open Access | Times Cited: 9
Cenobamate as an Early Adjunctive Treatment in Drug-Resistant Focal-Onset Seizures: An Observational Cohort Study
Yaroslav Winter, Raya Abou Dargham, Susana Patiño Tobón, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 733-742
Open Access | Times Cited: 8
Using artificial intelligence to optimize anti-seizure treatment and EEG-guided decisions in severe brain injury
Zade Akras, Jin Jing, M. Brandon Westover, et al.
Neurotherapeutics (2025), pp. e00524-e00524
Open Access | Times Cited: 1
Effects of physical exercise in people with epilepsy: A systematic review and meta-analysis
Iratxe Duñabeitia, Iraia Bidaurrazaga‐Letona, José Carlos Diz, et al.
Epilepsy & Behavior (2022) Vol. 137, pp. 108959-108959
Closed Access | Times Cited: 33
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study
Kelly G. Knupp, Ingrid E. Scheffer, Berten Ceulemans, et al.
Epilepsia (2022) Vol. 64, Iss. 1, pp. 139-151
Open Access | Times Cited: 32
Metabolomics Provides Novel Insights into Epilepsy Diagnosis and Treatment: A Review
Wanlin Lai, Dan Du, Lei Chen
Neurochemical Research (2022) Vol. 47, Iss. 4, pp. 844-859
Closed Access | Times Cited: 31
TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model
Qiang Shao, Che-Wei Chang, Zhiyong Li, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 642
Open Access | Times Cited: 29
The pharmacological treatment of epilepsy in adults
Torbjörn Tomson, Johan Zelano, Yew Li Dang, et al.
Epileptic Disorders (2023) Vol. 25, Iss. 5, pp. 649-669
Open Access | Times Cited: 20
Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy
Laurent M. Willems, Milena van der Goten, Felix von Podewils, et al.
CNS Drugs (2023) Vol. 37, Iss. 6, pp. 531-544
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top